Delphi Ventures
Delphi Ventures is a venture capital firm that has focused on investing in biotechnology and medical devices for over two decades. With more than $1.1 billion in committed capital, Delphi Ventures has funded over 170 companies. More than 110 of our portfolio companies have either completed an initial public offering or have been acquired by a leading healthcare corporation.
How to reach
X · Twitter
Website
Key partners
- Tom Shaughnessy@Shaughnessy119
- Yan Liberman@YanLiberman
- Anil Lulla@anillulla
Editor's notes
Research-driven; balance sheet investing. Co-invested with Anagram in Solana 2025.
Team
4 listedTeam members and their professional contacts are gated. Request access to view this section.